c-ABL-IN-2

Modify Date: 2024-04-03 15:52:35

c-ABL-IN-2 structure	Common Name	c-ABL-IN-2
	CAS Number	2574593-54-5	Molecular Weight	344.41
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₁H₂₀N₄O	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of c-ABL-IN-2

c-ABL-IN-2 is a potent inhibitor of c-Abl. Activation of c-Abl has been implicated in various diseases, notably cancer. c-ABL-IN-2 has the potential for the research of neurodegenerative diseases (amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD) and cancer (extracted from patent WO2020260871A1, compound 25)[1].

Name	c-ABL-IN-2

Description	c-ABL-IN-2 is a potent inhibitor of c-Abl. Activation of c-Abl has been implicated in various diseases, notably cancer. c-ABL-IN-2 has the potential for the research of neurodegenerative diseases (amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD) and cancer (extracted from patent WO2020260871A1, compound 25)[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Protein Tyrosine Kinase/RTK >> Bcr-Abl Research Areas >> Neurological Disease
References	[1]. Rebecca PAUL, et al. New compounds and methods. Patent WO2020260871A1.

Molecular Formula	C₂₁H₂₀N₄O
Molecular Weight	344.41

c-ABL-IN-2

Use of c-ABL-IN-2

Names

c-ABL-IN-2 Biological Activity

Chemical & Physical Properties